GlobeNewswire Inc.··NaNeumora to Unveil 2025 Results as Pipeline Advances Toward Critical Trial Readouts
Neumora Therapeutics will report 2025 financial results March 30, 2026, with major KOASTAL trial readouts anticipated in Q2 2026.
NMRAfinancial resultsclinical-stage biopharmaceutical